A view that puberty blocker use for trans youth in New Zealand needs tighter supervision.
New Zealand's use of puberty blockers is seven times higher than comparable countries.
Paediatric Endocrinologist, Paul Hofman says they shouldn't be banned as they can be effective in some cases.
He told Heather du Plessis-Allan it's not settled science.
Hofman says the evidence for puberty blocker's efficacy is not as strong as many think.
LISTEN ABOVE

Enda Brady: UK correspondent on Prime Minister Starmer indicating the UK will be growing partnership with EU
04:36

Sam Dickie: Fisher Funds expert on the ongoing economic costs of the Iran war
03:25

Jamie Mackay: The Country host on farmer voicing concerns about long-term impacts of Iran conflict
03:27